Hypercalcemia
Hypercalcemia refers to an abnormal increase in serum ionized calcium concentration. When the amount of calcium entering the extracellular fluid (intestines, bones) exceeds the amount of calcium excreted (intestines, kidneys), hypercalcemia occurs, and the blood calcium concentration is higher than 2.75mmol/L. There are two major causes of hypercalcemia: PTH-dependent and PTH-independent hypercalcemia. It is generally believed that when serum calcium is above 3.75mmol/L, hypercalcemic crisis may occur, which is life-threatening if not properly handled and is a clinical emergency.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Primary hyperparathyroidism is often... -
Related symptoms:
Fatigue stupor headache depression fatigue -
Concurrent disease:
Related Drugs
Clodronate Disodium Injection
Indication: 1. Hypercalcemia complicated by malignant tumors. 2. Bone pain caused by osteolytic cancer metastasis. 3. Can avoid or delay osteolytic bone metastasis of malignant tumors. 4. Various types of osteoporosis.
Manufacturer:
Nanjing Pharmaceutical FACTORY Co., Ltd.
Clodronate Disodium Injection
Indication: 1. Hypercalcemia complicated by malignant tumors. 2. Bone pain caused by osteolytic cancer metastasis. 3. Can prevent or delay osteolytic bone metastasis of malignant tumors. 4. Various types of osteoporosis.
Manufacturer:
Jinling Pharmaceutical Co., Ltd. Nanjing Jinling Pharmaceutical Factory
Clodronate Disodium Injection
Indication: 1. Hypercalcemia complicated by malignant tumors. 2. Bone pain caused by osteolytic cancer metastasis. 3. Can prevent or delay osteolytic bone metastasis of malignant tumors. 4. Various types of osteoporosis.
Clodronate Disodium Injection
Indication: 1. Hypercalcemia complicated by malignant tumors. 2. Bone pain caused by osteolytic cancer metastasis. 3. Can prevent or delay osteolytic bone metastasis of malignant tumors. 4. Various types of osteoporosis.
Pamidronate disodium
Indication: Hypercalcemia complicated by malignancy and bone pain caused by osteolytic cancer metastasis.
Pamidronate disodium
Indication: Hypercalcemia complicated by malignancy and bone pain caused by osteolytic cancer metastasis.
Zoledronic Acid for Injection
Indication: Hypercalcemia drugs, treatment of tumor bone metastasis and prevention of skeletal complications.
Manufacturer:
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
Ibandronate Sodium Injection
Indication: This product is suitable for hypercalcemia caused by malignant tumors with or without bone metastasis: used to treat bone pain caused by osteolytic bone metastasis of malignant tumors.
Manufacturer:
Shijiazhuang Kaida Bioengineering Co., Ltd.
Ibandronate Sodium Injection
Indication: This product is suitable for hypercalcemia caused by malignant tumors with or without bone metastasis: used to treat bone pain caused by osteolytic bone metastasis of malignant tumors.
Manufacturer:
Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.
Ibandronate Sodium Injection
Indication: Hypercalcemia due to malignancy with or without bone metastases.
Manufacturer:
Chengdu Easton Bio Pharmaceuticals Co., Ltd.
Related Ingredients
-
CLODRONIC ACID list
10596-23-3 -
Clodronate disodium Salt list
22560-50-5 -
Disodium pamidronate list
109552-15-0 -
Zoledronic acid list
118072-93-8 -
Ibandronate sodium list
138844-81-2